Challenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of cytokine-stimulated NK cells as a strategy to prevent fratricide-Reference-Cited by-同舟云学术

Challenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of cytokine-stimulated NK cells as a strategy to prevent fratricide

Published:2023-07 Issue:7 Volume:25 Page:763-772
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Karvouni Maria^ORCID,Vidal-Manrique Marcos^ORCID,Susek Katharina H.^ORCID,Hussain Alamdar,Gilljam Mari^ORCID,Zhang Yanliang,Gray J. Dixon,Lund Johan,Kaufmann Gunnar,Ljunggren Hans-Gustaf^ORCID,Ji Henry,Lundqvist Andreas,Wagner Arnika K.,Guo Wenzhong,Alici Evren

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference52 articles.

1. The diagnosis and treatment of multiple myeloma;Gerecke;Dtsch Arztebl Int,2016

2. Multiple myeloma epidemiology and survival: a unique malignancy;Kazandjian;Semin Oncol,2016

3. Rapidly changing myeloma epidemiology in the general population: increased incidence, older patients, and longer survival;Turesson;Eur J Haematol,2018

4. Multiple myeloma: a review of the epidemiologic literature;Alexander;Int J Cancer,2007

5. Allogeneic stem cell transplantation for multiple myeloma: is there a future?;Dhakal;Bone Marrow Transplant,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD38 deletion to preserve CAR T cell metabolism and promote functional persistence;Molecular Therapy: Oncology;2024-09

2. Beyond BCMA: the next wave of CAR T cell therapy in multiple myeloma;Frontiers in Oncology;2024-05-10

3. Harnessing the Power of CAR-NK Cells: A Promising Off-the-Shelf Therapeutic Strategy for CD38-Positive Malignancies;IRAN J IMMUNOL;2023

4. Acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation presenting as pericardial effusion;Blood Science;2023-10

5. CAR T cell therapy in multiple myeloma, where are we now and where are we heading for?;European Journal of Haematology;2023-08-07